Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H11NO7 |
Molecular Weight | 341.2717 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2C=C(C3=C(C4=C(OCO4)C=C3C(O)=O)C2=CC=C1)[N+]([O-])=O
InChI
InChIKey=BBFQZRXNYIEMAW-UHFFFAOYSA-N
InChI=1S/C17H11NO7/c1-23-12-4-2-3-8-9(12)5-11(18(21)22)14-10(17(19)20)6-13-16(15(8)14)25-7-24-13/h2-6H,7H2,1H3,(H,19,20)
Aristolochic acid (AA-I), a naturally occurring nitrophenanthrene carboxylic acid, commonly found in the plant family Aristolochiaceae, that are used in traditional Chinese medicine. Aristolochic acid exhibits nephrotoxic, carcinogenic, and mutagenic activities and can cause aristolochic acid nephropathy, and urothelial malignancies. The FDA has issued a strong warning to consumers to avoid herbs containing the chemical aristolochic acid. The mechanisms underlying AA-I toxicity in the kidneys are poorly understood. However, was found a protein α-actinin-4 that is inhibited by AA-I, resulting in kidney disease.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q9UNQ0|||Q86V64 Gene ID: 9429.0 Gene Symbol: ABCG2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/26183576 |
|||
Target ID: O43707 Gene ID: 81.0 Gene Symbol: ACTN4 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/27080942 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
[Current status of injury caused by Chinese herbal medicine and its counter measure]. | 2001 Jan |
|
Contribution of different taste cells and signaling pathways to the discrimination of "bitter" taste stimuli by an insect. | 2002 Aug 15 |
|
Antithrombin activity of some constituents from Origanum vulgare. | 2002 Dec |
|
[Comparison among families of Mutong]. | 2002 Jun |
|
[Influence of long-term use of low dose caulis Aristolochiae manshuriensis on partial nephrectomized rats]. | 2002 Jun |
|
Enzymatic activity and inhibition of the neurotoxic complex vipoxin from the venom of Vipera ammodytes meridionalis. | 2002 Nov-Dec |
|
Determination of aristolochic acid I and II in North American species of Asarum and Aristolochia. | 2002 Oct |
|
Mechanism of endothelin-1-induced cytosolic Ca(2+) mobility in cultured H9c2 myocardiac ventricular cells. | 2002 Oct |
|
Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? | 2002 Oct 10 |
|
Bradykinin increases permeability by calcium and 5-lipoxygenase in the ECV304/C6 cell culture model of the blood-brain barrier. | 2002 Oct 25 |
|
[Aristolochic acid induced transdifferentiation and apoptosis in human tubular epithelial cells in vitro]. | 2002 Sep |
|
An LC/DAD-UV/MS method for the rapid detection of aristolochic acid in plant preparations. | 2002 Sep |
|
Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure. | 2002 Sep 10 |
|
Involvement of phosphatidic acid in both degranulation and oxidative activity in fMet-Leu-Phe stimulated polymorphonuclear leukocytes. | 2003 |
|
Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date. | 2003 |
|
Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy. | 2003 Apr |
|
Transgene-derived hepatocyte growth factor attenuates reactive renal fibrosis in aristolochic acid nephrotoxicity. | 2003 Dec |
|
The importance of a histology-based diagnosis of interstitial nephropathy in two patients with renal insufficiency. | 2003 Feb |
|
Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure. | 2003 Feb |
|
Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. | 2003 Jan |
|
[Clinical analysis of two children with aristolochic acid nephropathy]. | 2003 Jul |
|
The role of phospholipases A2 in the stimulation of neutrophil motility by cobra venoms. | 2003 Mar |
|
Zona pellucida induces activation of phospholipase A2 during acrosomal exocytosis in guinea pig spermatozoa. | 2003 Mar |
|
[A comparative study of manchurian Dutchmanspipe and antibiotics induced acute tubular necrosis in renal cellular biological features]. | 2003 May |
|
[Provide against possible trouble--on knowledge, prevention and treatment of adverse drug reactions]. | 2003 May |
|
Determination of aristolochic acids by capillary electrophoresis. | 2003 May-Aug |
|
H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling. | 2003 Nov |
|
Aristolochic acid nephropathy and the peritoneum: Functional, structural, and molecular studies. | 2003 Nov |
|
Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. | 2003 Nov 24 |
|
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase. | 2003 Oct |
|
Effect of indomethacin on force responses and sarcoplasmic reticulum function in skinned skeletal muscle fibers and cytosolic [Ca2+] in myotubes. | 2003 Oct |
|
Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert. | 2003 Oct 16 |
|
The nephrotoxicity of Aristolochia manshuriensis in rats is attributable to its aristolochic acids. | 2003 Sep |
|
Bid activates multiple mitochondrial apoptotic mechanisms in primary hepatocytes after death receptor engagement. | 2003 Sep |
|
Arachidonic acid regulates surface expression of epithelial sodium channels. | 2003 Sep 19 |
|
Role of phospholipase A2 activation and calcium in CYP2E1-dependent toxicity in HepG2 cells. | 2003 Sep 5 |
|
Insecticidal activity of chemical constituents from Aristolochia pubescens against Anticarsia gemmatalis larvae. | 2004 Apr |
|
Transcriptional activation of Igl, the gene for indole formation in Zea mays: a structure-activity study with elicitor-active N-acyl glutamines from insects. | 2004 Apr |
|
DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. | 2004 Apr |
|
[Cellular mechanism of renal proximal tubular epithelial cell injury induced by aristolochic acid I and aristololactam I]. | 2004 Feb |
|
Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts. | 2004 Feb 1 |
|
Phospholipase C, but not InsP3 or DAG, -dependent activation of the muscarinic receptor-operated cation current in guinea-pig ileal smooth muscle cells. | 2004 Jan |
|
An easy and rapid method to determine aristolochic acids I and II with high sensitivity. | 2004 Jan |
|
Herbal bioactivation: the good, the bad and the ugly. | 2004 Jan 9 |
|
Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. | 2004 Jun |
|
Aristolochic acid nephropathy: what we know and what we have to do. | 2004 Jun |
|
Regulation of Na+ transport by aldosterone: signaling convergence and cross talk between the PI3-K and MAPK1/2 cascades. | 2004 Jun |
|
Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway. | 2004 Jun 11 |
|
Purification of a Class B1 platelet aggregation inhibitor phospholipase A2 from Indian cobra (Naja Naja) venom. | 2004 Mar |
|
NMR regulatory analysis: determination and characterization of Chinese-herb aristolochic acids. | 2004 Mar |
Patents
Sample Use Guides
The FDA has issued a strong warning to consumers to avoid herbs containing the chemical aristolochic acid
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27080942
It was studied the mechanism of aristolochic acid I (AA-I) nephrotoxicity by analyzing the uptake, subcellular distribution, and intracellular targets of AA-I in the human kidney cell line HK-2 using immunocytochemistry, immunoprecipitation, and LC-MS/MS. In HK-2 cells incubated with 20 ug/mL AA-I for different periods of time (up to 12 h). AA-I was detected by a specific monoclonal antibody (MAb) against AA-I, both in the cytoplasm and nuclei. Nuclear localization depended on the exposure time. A protein with the molecular weight of 100 kDa was immunoprecipitated with the anti-AA-I MAb from the AA-I-treated cell lysates and was identified by LC-MS/MS as alpha-actinin-4
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C000228
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
2825
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
313-67-7
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
2236
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
m2047
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
ARISTOLOCHIC ACID
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
50413
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
DTXSID0040969
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
SUB12936MIG
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
206-238-3
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
100000077412
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
94218WFP5T
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY | |||
|
11926
Created by
admin on Fri Dec 15 17:19:45 GMT 2023 , Edited by admin on Fri Dec 15 17:19:45 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)